Patent ID: 7622257

Claim:
A method of screening for or identifying a pharmaceutical agent capable of modulating staufen function comprising the steps of: a) stimulating the CREB pathway of a neuron expressing a STAUFEN::indicator fusion protein, wherein the STAUFEN::indicator fusion protein is expressed from a DNA construct, which is operably linked to a promoter sequence, that is introduced into the neuron; b) measuring the STAUFEN function in the neuron; c) introducing a pharmaceutical agent of interest into the neuron, and d) measuring STAUFEN function, wherein a difference in the STAUFEN function measured in d) compared to the STAUFEN function of neurons of b) to which said pharmaceutical agent has not been administered identifies the pharmaceutical agent as one capable of modulating STAUFEN function, and wherein the STAUFEN function is measured by a step selected from the group of detecting the level of STAUFEN::indicator fusion protein expression, detecting the level of STAUFEN::indicator fusion protein mRNA produced, detecting the level of STAUFEN::indicator fusion protein produced, detecting trans location of STAUFEN::indicator fusion protein into dendrites, measuring downstream gene products regulated by a staufen gene product, and determining the distribution of neural granules in the cells.